Companies
- Companies
- Company details
Acrux Ltd
Out-licensing
Acrux Advances Clinical Development of Investigational Testosterone Spray for Women: Testosterone MDTS® for the Treatment of Female Androgen Insufficiency More
Nestorone® MDTS®: New Generation Contraceptive for Delivery by Acrux's Unique Spray Technology More
Oestradiol Spray for Women: Oestradiol MDTS for the Treatment of Menopausal Symptoms More
Phase I Clinical Development of Fentanyl MDTS for the Treatment of Severe Post-Operative Pain and Cancer-Associated Pain More
Related Reports
Market Research Reports provided by reports.innovaro.com
Nov 2010 - 40 pages - $500
Feb 2011 - 29 pages - $125
May 2011 - 38 pages - $125
Nov 2010 - 87 pages - $600
Jul 2010 - 61 pages - $750
Nov 2010 - 47 pages - $600
Sep 2010 - 29 pages - $15,200
Jun 2011 - 66 pages - $1,000
Sep 2011 - 102 pages - $1,000
Contact details
Nina Wilkins
Head office
© Copyright 1998-2012 Innovaro Europe Ltd 
All rights reserved. Terms and Conditions | Contact us